179 related articles for article (PubMed ID: 37919024)
1. Management of Monogenic and Syndromic Obesity.
Han JC; Rasmussen MC; Forte AR; Schrage SB; Zafar SK; Haqq AM
Gastroenterol Clin North Am; 2023 Dec; 52(4):733-750. PubMed ID: 37919024
[TBL] [Abstract][Full Text] [Related]
2. Setmelanotide: First Approval.
Markham A
Drugs; 2021 Feb; 81(3):397-403. PubMed ID: 33638809
[TBL] [Abstract][Full Text] [Related]
3. Genetics of Obesity in Humans: A Clinical Review.
Mahmoud R; Kimonis V; Butler MG
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232301
[TBL] [Abstract][Full Text] [Related]
4. Rare genetic forms of obesity: From gene to therapy.
Clément K; Mosbah H; Poitou C
Physiol Behav; 2020 Dec; 227():113134. PubMed ID: 32805220
[TBL] [Abstract][Full Text] [Related]
5. Clinical, molecular genetics and therapeutic aspects of syndromic obesity.
Geets E; Meuwissen MEC; Van Hul W
Clin Genet; 2019 Jan; 95(1):23-40. PubMed ID: 29700824
[TBL] [Abstract][Full Text] [Related]
6. Prader-Willi Syndrome and PCSK1 mutation: a novel presentation of combined syndromic and monogenic obesity.
Kostopoulou E; Spilioti DX; Pantzaris ND; Spiliotis BE
Eur Rev Med Pharmacol Sci; 2022 Apr; 26(7):2437-2442. PubMed ID: 35442499
[TBL] [Abstract][Full Text] [Related]
7. Genetic and hereditary aspects of childhood obesity.
Farooqi IS
Best Pract Res Clin Endocrinol Metab; 2005 Sep; 19(3):359-74. PubMed ID: 16150380
[TBL] [Abstract][Full Text] [Related]
8. Natural History of Obesity Due to POMC, PCSK1, and LEPR Deficiency and the Impact of Setmelanotide.
Wabitsch M; Farooqi S; Flück CE; Bratina N; Mallya UG; Stewart M; Garrison J; van den Akker E; Kühnen P
J Endocr Soc; 2022 Jun; 6(6):bvac057. PubMed ID: 35528826
[TBL] [Abstract][Full Text] [Related]
9. A Comprehensive Review of Syndromic Forms of Obesity: Genetic Etiology, Clinical Features and Molecular Diagnosis.
Carvalho LML; Jorge AAL; Bertola DR; Krepischi ACV; Rosenberg C
Curr Obes Rep; 2024 Jun; 13(2):313-337. PubMed ID: 38277088
[TBL] [Abstract][Full Text] [Related]
10. Screening for hormonal, monogenic, and syndromic disorders in obese infants and children.
Mason K; Page L; Balikcioglu PG
Pediatr Ann; 2014 Sep; 43(9):e218-24. PubMed ID: 25198446
[TBL] [Abstract][Full Text] [Related]
11. [Genetic obesities].
Pigeyre M; Romon M
Ann Endocrinol (Paris); 2007 Dec; 68(6):430-7. PubMed ID: 18022138
[TBL] [Abstract][Full Text] [Related]
12. Single Gene and Syndromic Causes of Obesity: Illustrative Examples.
Butler MG
Prog Mol Biol Transl Sci; 2016; 140():1-45. PubMed ID: 27288824
[TBL] [Abstract][Full Text] [Related]
13. Setmelanotide: a promising advancement for pediatric patients with rare forms of genetic obesity.
Trapp CM; Censani M
Curr Opin Endocrinol Diabetes Obes; 2023 Apr; 30(2):136-140. PubMed ID: 36722447
[TBL] [Abstract][Full Text] [Related]
14. Serum leptin concentrations in obese women with Down syndrome and Prader-Willi syndrome.
Cento RM; Proto C; Spada RS; Ragusa L; Reitano S; Napolitano V; Lanzone A
Gynecol Endocrinol; 1999 Feb; 13(1):36-41. PubMed ID: 10368796
[TBL] [Abstract][Full Text] [Related]
15. The influential role of genes in obesity.
Stein QP; Mroch AR; De Berg KL; Flanagan JD
S D Med; 2011; Spec No():12-5, 17. PubMed ID: 21717811
[TBL] [Abstract][Full Text] [Related]
16. Alteration of serum leptin and LEP/LEPR promoter methylation in Prader-Willi syndrome.
Wieting J; Jahn K; Buchholz V; Lichtinghagen R; Deest-Gaubatz S; Bleich S; Eberlein CK; Deest M; Frieling H
Psychoneuroendocrinology; 2022 Sep; 143():105857. PubMed ID: 35803048
[TBL] [Abstract][Full Text] [Related]
17. An evaluation of setmelanotide injection for chronic weight management in adult and pediatric patients with obesity due to Bardet-Biedl syndrome.
Lazareva J; Brady SM; Yanovski JA
Expert Opin Pharmacother; 2023 Apr; 24(6):667-674. PubMed ID: 37013719
[TBL] [Abstract][Full Text] [Related]
18. Syndromic and Monogenic Obesity: New Opportunities Due to Genetic-Based Pharmacological Treatment.
Kalinderi K; Goula V; Sapountzi E; Tsinopoulou VR; Fidani L
Children (Basel); 2024 Jan; 11(2):. PubMed ID: 38397265
[TBL] [Abstract][Full Text] [Related]
19. Rare genetic forms of obesity in childhood and adolescence: A narrative review of the main treatment options with a focus on innovative pharmacological therapies.
Mainieri F; La Bella S; Rinaldi M; Chiarelli F
Eur J Pediatr; 2024 Apr; 183(4):1499-1508. PubMed ID: 38227053
[TBL] [Abstract][Full Text] [Related]
20. Beneficial Effects of Setmelanotide in a 5-Year-Old Boy With POMC Deficiency and on His Caregivers.
Dubern B; Lourdelle A; Clément K
JCEM Case Rep; 2023 May; 1(3):luad041. PubMed ID: 37908575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
